The global hypopigmentation disorder treatment market refers to therapies, medications, and dermatological procedures used to manage skin conditions that cause loss of pigmentation, including vitiligo, albinism, and post-inflammatory hypopigmentation. The market experiences growth because more people develop autoimmune skin disorders and more people learn about cosmetic dermatology and people need better treatment solutions.